Research Highlight |
Featured
-
-
-
-
-
-
Research Highlight |
Dalcetrapib raises HDL-cholesterol level, but does not reduce cardiac risk
- Gregory B. Lim
-
-
-
ACE inhibitors and ARBs in HFpEF
Could it be TIME to abandon BMCs?
Aspirin ASPIREs to reduce vascular events after VTE
Antibodies against PCSK9—a new era of therapy
Phase III trial of mipomersen in heterozygous FH